article thumbnail

Congenital fibrinogen deficiency market forecast to reach $800m across 3MM by 2031

Pharmaceutical Technology

Both pipeline products use Biotest’s newly developed production facility, which enables improved manufacturing of fibrinogen with higher purity, defined concentrations, viral safety, and good solubility.

Marketing 130
article thumbnail

Roche signs definitive share purchase agreement with long-term partner TIB.

The Pharma Data

The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments. TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years. About TIB Molbiol.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rare Kidney Diseases: Exploring The Uncommon Rare Conditions

Roots Analysis

However, the rising incidence and prevalence of rare kidney disease, with poor outcomes and high cost has led to an increased research activity in this domain. In August 2023, Cabaletta Bio entered into a manufacturing agreement with WuXi Advanced Therapies to advance the development of CABA-201 for patients with autoimmune diseases.

article thumbnail

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

The Pharma Data

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, It’s critical to quickly and accurately identify variants to inform ongoing research – including the ongoing development of therapeutics and vaccines. 3 and Delta.

article thumbnail

Global Roundup: Overland Pharma Launches in China to Provide Access to Breakthrough Therapies

The Pharma Data

With the launch of Overland, we are creating a robust research and development engine in parallel with the significant growth and opportunity presented by Asia’s evolving biotech industry. BioMed X – Germany-based BioMed X Institute completed its first joint research project in neuroscience with Boehringer Ingelheim.

In-Vivo 52
article thumbnail

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

XTalks

“Rare disease clinical trials are complex due to the additional scientific, medical, operational and regulatory requirements of newly emerging advanced therapies, such as gene therapy,” says Dr. Terence Eagleton, MB BS, Senior Medical Director at the global clinical research organization (CRO) Medpace.

article thumbnail

Top 7 Pharma Industry Leaders in 2020 By the Numbers

Delveinsight

The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms. Johnson and Johnson manufactures a variety of drugs to treat several indications. billion in 2020.